Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells.
about
Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host.Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target.
P2860
Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells.
@en
type
label
Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells.
@en
prefLabel
Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells.
@en
P2093
P2860
P1433
P1476
Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells
@en
P2093
Alexander A Perakis
Anne V Philips
Elizabeth A Mittendorf
George E Peoples
Gheath Alatrash
Guy T Clifton
Jeffrey J Molldrem
Karen Clise-Dwyer
P2860
P304
P356
10.1158/0008-5472.CAN-16-2774
P407
P577
2017-08-17T00:00:00Z